首页> 外文OA文献 >Antileishmanial activity of extracts from Libidibia ferrea: development of in vitro and in vivo tests
【2h】

Antileishmanial activity of extracts from Libidibia ferrea: development of in vitro and in vivo tests

机译:开发体外和体内试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Treatment of cutaneous leishmaniasis (CL) is difficult due to the scarce number of drugs able to eliminate completely the intracellular form of the parasite. In the present study, the aim was to evaluate: i) phytochemical properties of extracts from Libidibia ferrea; ii) antileishmanial activity of extracts from L. ferrea against promastigotes and amastigotes of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) guyanensis; iii) the effects of topical treatment using hydrogel containing active extract of L. ferrea on golden hamsters infected with L. (L.) amazonensis. Extracts from leaves, branches and fruits of L. ferrea were obtained with hexane and methanol and were tested by in vitro assays in promastigotes and murine macrophages J774 experimentally infected with amastigotes of Leishmania. Groups of hamsters with CL received topical treatment with a formulation of extract (10%) hydrogels, 50 mg. day(-1) for 40 days. In vitro activity of FrMeOH (methanolic extract from fruits without seeds) resulted in significant reduction of viable promastigotes of L. (L.) amazonensis (IC50 of 15.4 mu g. mL(-1)) and demonstrated inhibition potential of amastigote forms of L. (L.) amazonensis and L. (V.) guyanensis and low cytotoxicity in macrophages. The overall data of topical treatment with extract hydrogels (GelFrMeOH) showed that lesion sizes were significantly reduced (42.78%), with low parasite burden by RT-qPCR and culture analysis by microscopy examination, and with histopathological findings such as lower inflammatory cell infiltration 40 days after treatment. Chemical analysis demonstrated FrMeOH contains high levels of phenolic compounds. The results indicate a possible alternative therapy for CL using phytotherapics. KEYWORDS: cutaneous leishmaniasis, natural products, topical formulations, experimental treatment
机译:由于能够完全消除寄生虫的细胞内形式的药物稀缺的药物,皮肤嗜利亚畸变(CL)的治疗难以。在本研究中,目的是评估:i)来自双利法雷的提取物的植物化学性质; II)L. Ferra Zhease的癌症癌症癌症癌症和Leishmania(Leishmania)Amazonensis和Leishmania(Viannia)Guyanensis的癌症癌症营养活动; iii)使用L.(L.)亚马逊感染L. Ferraa的H. Ferraa的水凝胶的局部处理的影响。用己烷和甲醇获得L. Ferra的叶片,分支和果实的萃取,并通过在Promastigotes和鼠巨噬细胞J774的体外测定进行测试,实验感染Leishmania的Amastigotes。具有CL的仓鼠组接受了局部处理,其配方提取物(10%)水凝胶,50mg。天(-1)40天。 FrMeOH的体外活性(来自没有种子的果实的甲醇提取物)导致L的活性突起显着减少了L.(L.)亚马逊(IC50的15.4μg),并证明了L的Amastigotoote形式的抑制潜力。(L.)Amazonensis和L.(V.)巨蟹座和巨噬细胞的低细胞毒性。用提取物水凝胶(GelfrmeOH)的局部治疗的总体数据显示,病变尺寸显着降低(42.78%),通过RT-QPCR的寄生菌和微观检查的培养分析,以及诸如降低炎症细胞浸润40的组织病理学发现治疗后的天。化学分析证明FrmeOH含有高水平的酚类化合物。结果表明使用植物治疗方法对CL可能的替代疗法。关键词:皮肤利什曼病,天然产物,局部配方,实验治疗

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号